Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-22

Clinical Trial Update: Eligard Observational Registry for Patients With Prostate Cancer

View source ↗

Summary

Update indicating the Eligard observational registry for patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eligard (leuprolide acetate)

Snippet

Sponsor: CMX Research | Conditions: Cancer of the Prostate | Status: COMPLETED